Top

BMC Medicine

Published in:

Open Access 01-12-2022 | Research article

Consumption of coffee and tea with all-cause and cause-specific mortality: a prospective cohort study

Authors: Yanchun Chen, Yuan Zhang, Mengnan Zhang, Hongxi Yang, Yaogang Wang

Published in: BMC Medicine | Issue 1/2022

Abstract

Background

Previous studies suggested that moderate coffee and tea consumption are associated with lower risk of mortality. However, the association between the combination of coffee and tea consumption with the risk of mortality remains unclear. This study aimed to evaluate the separate and combined associations of coffee and tea consumption with all-cause and cause-specific mortality.

Methods

This prospective cohort study included 498,158 participants (37–73 years) from the UK Biobank between 2006 and 2010. Coffee and tea consumption were assessed at baseline using a self-reported questionnaire. All-cause and cause-specific mortalities, including cardiovascular disease (CVD), respiratory disease, and digestive disease mortality, were obtained from the national death registries. Cox regression analyses were conducted to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).

Results

After a median follow-up of 12.1 years, 34,699 deaths were identified. The associations of coffee and tea consumption with all-cause and cause-specific mortality attributable to CVD, respiratory disease, and digestive disease were nonlinear (all P nonlinear < 0.001). The association between separate coffee consumption and the risk of all-cause mortality was J-shaped, whereas that of separate tea consumption was reverse J-shaped. Drinking one cup of coffee or three cups of tea per day seemed to link with the lowest risk of mortality. In joint analyses, compared to neither coffee nor tea consumption, the combination of < 1–2 cups/day of coffee and 2–4 cups/day of tea had lower mortality risks for all-cause (HR, 0.78; 95% CI: 0.73–0.85), CVD (HR, 0.76; 95% CI: 0.64–0.91), and respiratory disease (HR, 0.69; 95% CI: 0.57–0.83) mortality. Nevertheless, the lowest HR (95% CI) of drinking both < 1–2 cup/day of coffee and ≥ 5 cups/day of tea for digestive disease mortality was 0.42 (0.34–0.53).

Conclusions

In this large prospective study, separate and combined coffee and tea consumption were inversely associated with all-cause and cause-specific mortality.

Available only for authorised users

Kondo Y, Goto A, Noma H, Iso H, Hayashi K, Noda M. Effects of coffee and tea consumption on glucose metabolism: a systematic review and network meta-analysis. Nutrients. 2018:11(1). https://doi.org/10.3390/nu11010048.

Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014;129(6):643–59. https://doi.org/10.1161/CIRCULATIONAHA.113.005925.CrossRefPubMed

Nie J, Yu C, Guo Y, Pei P, Chen L, Pang Y, et al. Tea consumption and long-term risk of type 2 diabetes and diabetic complications: a cohort study of 0.5 million Chinese adults. Am J Clin Nutr. 2021;114(1):194–202. https://doi.org/10.1093/ajcn/nqab006.CrossRefPubMedPubMedCentral

Yu C, Tang H, Guo Y, Bian Z, Yang L, Chen Y, et al. Hot tea consumption and its interactions with alcohol and tobacco use on the risk for esophageal cancer: a population-based cohort study. Ann Intern Med. 2018;168(7):489–97. https://doi.org/10.7326/M17-2000.CrossRefPubMedPubMedCentral

Park SY, Freedman ND, Haiman CA, Le Marchand L, Wilkens LR, Setiawan VW. Association of Coffee consumption with total and cause-specific mortality among nonwhite populations. Ann Intern Med. 2017;167(4):228–35. https://doi.org/10.7326/M16-2472.CrossRefPubMedPubMedCentral

Chung M, Zhao N, Wang D, Shams-White M, Karlsen M, Cassidy A, et al. Dose-response relation between tea consumption and risk of cardiovascular disease and all-cause mortality: a systematic review and meta-analysis of population-based studies. Adv Nutr. 2020;11(4):790–814. https://doi.org/10.1093/advances/nmaa010.CrossRefPubMedPubMedCentral

Zhao Y, Wu K, Zheng J, Zuo R, Li D. Association of coffee drinking with all-cause mortality: a systematic review and meta-analysis. Public Health Nutr. 2015;18(7):1282–91. https://doi.org/10.1017/S1368980014001438.CrossRefPubMed

de Koning Gans JM, Uiterwaal CS, van der Schouw YT, Boer JM, Grobbee DE, Verschuren WM, et al. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol. 2010;30(8):1665–71. https://doi.org/10.1161/ATVBAHA.109.201939.CrossRefPubMed

Montagnana M, Favaloro EJ, Lippi G. Coffee intake and cardiovascular disease: virtue does not take center stage. Semin Thromb Hemost. 2012;38(2):164–77. https://doi.org/10.1055/s-0032-1301414.CrossRefPubMed

10.

Loftfield E, Cornelis MC, Caporaso N, Yu K, Sinha R, Freedman N. Association of coffee drinking with mortality by genetic variation in caffeine metabolism: findings from the UK Biobank. JAMA Intern Med. 2018;178(8):1086–97. https://doi.org/10.1001/jamainternmed.2018.2425.CrossRefPubMedPubMedCentral

11.

Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012;366(20):1891–904. https://doi.org/10.1056/NEJMoa1112010.CrossRefPubMedPubMedCentral

12.

Kokubo Y, Iso H, Saito I, Yamagishi K, Yatsuya H, Ishihara J, et al. The impact of green tea and coffee consumption on the reduced risk of stroke incidence in Japanese population: the Japan public health center-based study cohort. Stroke. 2013;44(5):1369–74. https://doi.org/10.1161/STROKEAHA.111.677500.CrossRefPubMed

13.

Zhang Y, Yang H, Li S, Li WD, Wang Y. Consumption of coffee and tea and risk of developing stroke, dementia, and poststroke dementia: a cohort study in the UK Biobank. PLoS Med. 2021;18(11):e1003830. https://doi.org/10.1371/journal.pmed.1003830.CrossRefPubMedPubMedCentral

14.

Komorita Y, Iwase M, Fujii H, Ohkuma T, Ide H, Jodai-Kitamura T, et al. Additive effects of green tea and coffee on all-cause mortality in patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry. BMJ Open Diabetes Res Care. 2020;8:1. https://doi.org/10.1136/bmjdrc-2020-001252.CrossRef

15.

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. https://doi.org/10.1371/journal.pmed.1001779.CrossRefPubMedPubMedCentral

16.

Palmer LJ. UK Biobank: bank on it. Lancet. 2007;369(9578):1980–2. https://doi.org/10.1016/S0140-6736(07)60924-6.CrossRefPubMed

17.

Collins R. What makes UK Biobank special? Lancet. 2012;379(9822):1173–4. https://doi.org/10.1016/s0140-6736(12)60404-8.CrossRefPubMed

18.

Inoue-Choi M, Ramirez Y, Cornelis MC. Berrington de Gonzalez A, Freedman ND, Loftfield E: Tea consumption and all-cause and cause-specific mortality in the UK Biobank : a prospective cohort study. Ann Intern Med. 2022;175(9):1201–11. https://doi.org/10.7326/M22-0041.CrossRefPubMed

19.

Liu D, Li ZH, Shen D, Zhang PD, Song WQ, Zhang WT, et al. Association of sugar-sweetened, artificially sweetened, and unsweetened coffee consumption with all-cause and cause-specific mortality : a large prospective cohort study. Ann Intern Med. 2022;175(7):909–17. https://doi.org/10.7326/M21-2977.CrossRefPubMed

20.

Textor J, Hardt J, Knuppel S. DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology. 2011;22(5):745. https://doi.org/10.1097/EDE.0b013e318225c2be.CrossRefPubMed

21.

McEvoy CT, Guyer H, Langa KM, Yaffe K. Neuroprotective diets are associated with better cognitive function: the health and retirement study. J Am Geriatr Soc. 2017;65(8):1857–62. https://doi.org/10.1111/jgs.14922.CrossRefPubMedPubMedCentral

22.

Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016;133(2):187–225. https://doi.org/10.1161/CIRCULATIONAHA.115.018585.CrossRefPubMedPubMedCentral

23.

Liao SG, Lin Y, Kang DD, Chandra D, Bon J, Kaminski N, et al. Missing value imputation in high-dimensional phenomic data: imputable or not, and how? BMC Bioinformatics. 2014;15:346. https://doi.org/10.1186/s12859-014-0346-6.CrossRefPubMedPubMedCentral

24.

Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Statistics in medicine. 2010;29(9):1037–57. https://doi.org/10.1002/sim.3841.CrossRefPubMed

25.

Sepidarkish M, Omani-Samani R, Mansournia MA, Yekaninejad MS, Mardi-Mamaghani A, Vesali S, et al. The casual effect of lifestyle factors on outcomes of assisted reproductive techniques: a protocol study on Iranian infertile couples. Reprod Health. 2018;15(1):210. https://doi.org/10.1186/s12978-018-0655-8.CrossRefPubMedPubMedCentral

26.

Patel MI, Wang A, Kapphahn K, Desai M, Chlebowski RT, Simon MS, et al. Racial and ethnic variations in lung cancer incidence and mortality: results from the Women’s Health Initiative. J Clin Oncol. 2016;34(4):360–8. https://doi.org/10.1200/JCO.2015.63.5789.CrossRefPubMed

27.

Nordestgaard AT, Nordestgaard BG. Coffee intake, cardiovascular disease and all-cause mortality: observational and Mendelian randomization analyses in 95 000-223 000 individuals. Int J Epidemiol. 2016;45(6):1938–52. https://doi.org/10.1093/ije/dyw325.CrossRefPubMed

28.

Ruggiero E, Di Castelnuovo A, Costanzo S, Persichillo M, De Curtis A, Cerletti C, et al. Daily coffee drinking is associated with lower risks of cardiovascular and total mortality in a general italian population: results from the Moli-sani study. J Nutr. 2021;151(2):395–404. https://doi.org/10.1093/jn/nxaa365.CrossRefPubMed

29.

Kim SA, Tan LJ, Shin S. Coffee consumption and the risk of all-cause and cause-specific mortality in the Korean population. J Acad Nutr Diet. 2021;121(11):2221–32 e2224. https://doi.org/10.1016/j.jand.2021.03.014.CrossRefPubMed

30.

Wang X, Liu F, Li J, Yang X, Chen J, Cao J, et al. Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: the China-PAR project. Eur J Prev Cardiol. 2020;27(18):1956–63. https://doi.org/10.1177/2047487319894685.CrossRefPubMed

31.

Grosso G, Micek A, Godos J, Sciacca S, Pajak A, Martinez-Gonzalez MA, et al. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis. Eur J Epidemiol. 2016;31(12):1191–205. https://doi.org/10.1007/s10654-016-0202-2.CrossRefPubMed

32.

Saito E, Inoue M, Sawada N, Shimazu T, Yamaji T, Iwasaki M, et al. Association of green tea consumption with mortality due to all causes and major causes of death in a Japanese population: the Japan Public Health Center-based Prospective Study (JPHC Study). Ann Epidemiol. 2015;25(7):512–8 e513. https://doi.org/10.1016/j.annepidem.2015.03.007.CrossRefPubMed

33.

Gunter MJ, Murphy N, Cross AJ, Dossus L, Dartois L, Fagherazzi G, et al. Coffee drinking and mortality in 10 European countries: a multinational cohort study. Ann Intern Med. 2017;167(4):236–47. https://doi.org/10.7326/M16-2945.CrossRefPubMedPubMedCentral

34.

van Dam RM, Hu FB, Willett WC. Coffee, caffeine, and health. N Engl J Med. 2020;383(4):369–78. https://doi.org/10.1056/NEJMra1816604.CrossRefPubMed

35.

Zijp IM, Korver O, Tijburg LB. Effect of tea and other dietary factors on iron absorption. Crit Rev Food Sci Nutr. 2000;40(5):371–98. https://doi.org/10.1080/10408690091189194.CrossRefPubMed

36.

Martini D, Del Bo C, Tassotti M, Riso P, Del Rio D, Brighenti F, et al. Coffee consumption and oxidative stress: a review of human intervention studies. Molecules. 2016:21(8). https://doi.org/10.3390/molecules21080979.

37.

Lopez-Garcia E, van Dam RM, Qi L, Hu FB. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr. 2006;84(4):888–93. https://doi.org/10.1093/ajcn/84.4.888.CrossRefPubMed

38.

Tran KT, Coleman HG, McMenamin UC, Cardwell CR. Coffee consumption by type and risk of digestive cancer: a large prospective cohort study. Br J Cancer. 2019;120(11):1059–66. https://doi.org/10.1038/s41416-019-0465-y.CrossRefPubMedPubMedCentral

39.

Grosso G, Micek A, Godos J, Pajak A, Sciacca S, Galvano F, et al. Dietary flavonoid and lignan intake and mortality in prospective cohort studies: systematic review and dose-response meta-analysis. Am J Epidemiol. 2017;185(12):1304–16. https://doi.org/10.1093/aje/kww207.CrossRefPubMed

40.

Wang W, Zhang ZZ, Wu Y, Wang RQ, Chen JW, Chen J, et al. Xu ZD et al: (-)-Epigallocatechin-3-gallate ameliorates atherosclerosis and modulates hepatic lipid metabolic gene expression in apolipoprotein E knockout mice: involvement of TTC39B. Front Pharmacol. 2018;9:195. https://doi.org/10.3389/fphar.2018.00195.CrossRefPubMedPubMedCentral

41.

Teramoto M, Muraki I, Yamagishi K, Tamakoshi A, Iso H. Green tea and coffee consumption and all-cause mortality among persons with and without stroke or myocardial infarction. Stroke. 2021;52(3):957–65. https://doi.org/10.1161/STROKEAHA.120.032273.CrossRefPubMedPubMedCentral

42.

Oyama JI, Shiraki A, Nishikido T, Maeda T, Komoda H, Shimizu T, et al. EGCG, a green tea catechin, attenuates the progression of heart failure induced by the heart/muscle-specific deletion of MnSOD in mice. J Cardiol. 2017;69(2):417–27. https://doi.org/10.1016/j.jjcc.2016.05.019.CrossRefPubMed

43.

Chei CL, Loh JK, Soh A, Yuan JM, Koh WP. Coffee, tea, caffeine, and risk of hypertension: the Singapore Chinese Health Study. Eur J Nutr. 2018;57(4):1333–42. https://doi.org/10.1007/s00394-017-1412-4.CrossRefPubMed

44.

van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care. 2006;29(2):398–403. https://doi.org/10.2337/diacare.29.02.06.dc05-1512.CrossRefPubMed

45.

Cornelis MC, van Dam RM. Habitual coffee and tea consumption and cardiometabolic biomarkers in the UK Biobank: the role of beverage types and genetic variation. J Nutr. 2020;150(10):2772–88. https://doi.org/10.1093/jn/nxaa212.CrossRefPubMedPubMedCentral

46.

Kroon LA. Drug interactions and smoking: raising awareness for acute and critical care providers. Crit Care Nurs Clin North Am. 2006;18(1):53–62, xii. https://doi.org/10.1016/j.ccell.2005.11.007.CrossRefPubMed

47.

de Leon J, Diaz FJ, Rogers T, Browne D, Dinsmore L, Ghosheh OH, et al. A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(1):165–71. https://doi.org/10.1016/s0278-5846(02)00348-2.CrossRefPubMed

48.

Ferre S, O'Brien MC. Alcohol and caffeine: the perfect storm. J Caffeine Res. 2011;1(3):153–62. https://doi.org/10.1089/jcr.2011.0017.CrossRefPubMedPubMedCentral

49.

Schmit SL, Rennert HS, Rennert G, Gruber SB. Coffee consumption and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2016;25(4):634–9. https://doi.org/10.1158/1055-9965.EPI-15-0924.CrossRefPubMedPubMedCentral

50.

Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026–34. https://doi.org/10.1093/aje/kwx246.CrossRefPubMedPubMedCentral

Title: Consumption of coffee and tea with all-cause and cause-specific mortality: a prospective cohort study
Authors: Yanchun Chen
Yuan Zhang
Mengnan Zhang
Hongxi Yang
Yaogang Wang
Publication date: 01-12-2022
Publisher: BioMed Central
Published in: BMC Medicine / Issue 1/2022
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-022-02636-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Consumption of coffee and tea with all-cause and cause-specific mortality: a prospective cohort study

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Characterization of data-driven clusters in diabetes-free adults and their utility for risk stratification of type 2 diabetes

Prevention and control of non-communicable diseases in antenatal, intrapartum, and postnatal care: a systematic scoping review of clinical practice guidelines since 2011

Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

The impact and causal directions for the associations between diagnosis of ADHD, socioeconomic status, and intelligence by use of a bi-directional two-sample Mendelian randomization design

Links between electroconvulsive therapy responsive and cognitive impairment multimodal brain networks in late-life major depressive disorder

External validation of inpatient neonatal mortality prediction models in high-mortality settings